TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.

Emmanuel S Antonarakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.